Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück zu finanzen.net geht es hier.
SMI 10’656 -1.4%  SPI 13’734 -1.3%  Dow 31’029 0.3%  DAX 12’685 -2.5%  Euro 0.9961 -0.1%  EStoxx50 3’433 -2.3%  Gold 1’822 0.2%  Bitcoin 18’396 -4.0%  Dollar 0.9577 0.3%  Öl 116.0 0.2% 

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Strukturierte Produkte
>
24.05.2022 13:44:00

Why Roche Needs to Invest in At-Home Diagnostics

As the leader in medical diagnostics, Roche (OTC: RHHB.F) acted quickly to deliver valuable COVID-19 screening tests to the marketplace. Assisted by COVID-related sales, its diagnostics division is now delivering stronger growth than its larger pharmaceuticals division. But with the pandemic winding down, Roche must align its diagnostics pipeline with new trends in healthcare to keep that growth going.Medical doctor on remote meeting with patient.Roche's medical diagnostics division saw strong growth throughout 2021 and into the begining of 2022. First-quarter sales increased by 24% year over year, but the largest growth by far came from the 84% sales increase in point-of-care diagnostics solutions. These services develop diagnostic tests that support emergency rooms and clinics, as opposed to centralized labs.Continue reading
Weiter zum vollständigen Artikel bei "MotleyFool"

BITCOIN KURSZIEL 100'000 US-DOLLAR? WELCHER COIN KÖNNTE DER NÄCHSTE VERDOPPLER SEIN?

Informieren Sie sich aus erster Hand über Nachrichten, die Krypto-Kurse bewegen. Abonnieren Sie jetzt kostenlos unseren neuen Krypto-Newsletter!